Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 916542 Boston, MA
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,565,548
+$2,651,424 QoQ
Shares Held
4,004,867
+190.8% QoQ
Ownership
1.45%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 170 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names. AKBA ranks #17 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 318,320 $172,475,325
2 NBIX
Neurocrine Biosciences Inc
 441,371 $74,388,668
3 KNSA
Kiniksa Pharmaceuticals International, plc
 679,083 $43,427,357
4 RDY
Dr Reddys Laboratories Ltd
 2,260,243 $32,750,921
5 INDV
Indivior Pharmaceuticals, Inc.
 733,974 $30,114,953
6 AMRX
Amneal Pharmaceuticals, Inc.
 1,650,255 $28,565,914
7 BHC
Bausch Health Companies Inc.
 5,482,986 $27,031,120
8 ZTS
Zoetis Inc.
 364,442 $26,188,802

All Filings in AKBA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,565,548 4,004,867
2026-03-31 $1,914,124 1,377,068
2025-12-31 $3,541,592 2,199,747
2025-09-30 $5,863,906 2,147,951
2025-06-30 $4,914,673 1,350,185
2024-06-30 $4,144,650 4,063,383
2024-03-31 $9,716,851 5,309,755
2023-12-31 $8,575,223 6,915,503
2023-09-30 $8,234,776 7,223,488
2023-06-30 $6,826,222 7,460,353
2023-03-31 $4,190,509 7,483,053
2022-12-31 $4,317,721 7,483,053
2022-09-30 $2,364,644 7,483,053
2022-06-30 $2,590,682 7,339,043
2021-06-30 $40,310 10,636
2021-03-31 $7,108 2,100
2020-12-31 $2,341,038 836,085
2020-09-30 $1,805,485 719,317
2020-06-30 $50,327 3,706